All Type of News
‘Still high’ antibiotic prescription rates on AOM for children
Although antibiotic prescriptions of acute otitis media(AOM) for children have narrowly decreased, it was observed that they are still high.
The Health Insurance Review & Assessment Service(Director Myung-sae Sohn, H...
Hanmi Pharm launches complex treatment of rosuvastatin and ezetimibeHanmi Pharm(CEO Kwan-soon Lee) launched ‘Rosuzet,’ a complex drug combining ‘rosuvastatin,’ a substance of hyperlipidemia treatment, and ‘ezetimibe’ for the first time in the wo...
|
Interests of Minister Jin-yup Jung meeting with pharmaceutical group heads
Since Jin-yup Jung, the Minister of Health and Welfare, is unprecedentedly scheduled to talk to heads of pharmaceutical associations, such as the Korea Pharmaceutical Manufacturers Association and the Korean Research-...
The only Priligy generic by Shin Poong, given up by mostWhen it comes to Priligy(dapoxetine hydrochloride), a male premature ejaculation treatment which caused issues with patent lawsuits, the pharmaceutical industry has shown much l...
|
‘Aripiprazole’ schizophrenia market opens by its PMS expiration
The market of ‘aripiprazole’ drugs, schizophrenia treatments whose patent will be expired in PMS, will widely open on the coming 20th.
According to the Ministry of Food and Drug Safety, the number of products which a...
Cesentyx becomes a new psoriasis treatment optionThe industry has attracted attention if Novartis’s Cosentyx(generic name: secukinumab) will deliver a new treatment option to severe psoriasis patients.
Last September, Novarti...
|
Celltrion applied for European approval of biosimilar antibody for the second timeOn the 11th, Celltion announced the European Medicines Agency(EMA) received the document for the approval application of CT-P10 on the 10th of November(local time).
Since the c...
|
Winning of the Feburic patent trial neutralized sales prohibition of genericsAs companies which sell generics of ‘Feburic Tab(SK Chemicals, febuxostat),’ a gout treatment, won the patent suit, they neutralized the sales prohibition action. Thus, commerci...
|
Shocking price increase rates of OTC drugs sold in convenient stores
It was analyzed the Household Medicine Sales System, which allowed non-pharmacies, such as convenient stores, to sell antipyretics & analgesics, cold medicines and digestive medicines for 24/7, has slowed price raises...
Is Cervarix building up a cause for the NIP?
The company which owns ‘Cervarix,’ a uterine cervix cancer vaccine, announced data of an cost-benefit analysis that the drug is more cost-effective than its competing product, ‘Gardasil.’ In the circumstance where it ...
